Skip to main content
Heart Donate
Heart Donate
Search

Advertisement

FDA Poised For Decision On Controversial Alzheimer's Drug

03:09
Email
Dr. William Burke reviews a PET brain scan at Banner Alzheimer's Institute in Phoenix in 2018. An experimental Alzheimer's drug from Biogen and Eisai is on the verge of a Food and Drug Administration decision. (AP)
Dr. William Burke reviews a PET brain scan at Banner Alzheimer's Institute in Phoenix in 2018. An experimental Alzheimer's drug from Biogen and Eisai is on the verge of a Food and Drug Administration decision. (AP)

Related:

Advertisement

Advertisement

Listen Live
Loading...